TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$8.52M2013: -$15.93M2014: -$37.94M2015: -$61.51M2016: -$136.46M2017: -$76.67M2018: -$178.16M2019: -$286.29M2020: -$377.83M2021: -$264.50M2022: -$80.78M2023: -$46.26M2024: -$50.47M2025: $23.50M$23.50M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$23.50M+146.6%
2024-$50.47M-9.1%
2023-$46.26M+42.7%
2022-$80.78M+69.5%
2021-$264.50M+30.0%
2020-$377.83M-32.0%
2019-$286.29M-60.7%
2018-$178.16M-132.4%
2017-$76.67M+43.8%
2016-$136.46M-121.8%
2015-$61.51M-62.1%
2014-$37.94M-138.1%
2013-$15.93M-86.9%
2012-$8.52M—